Reference
Health Canada. Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury. Internet Document : 7 May 2018. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/pradaxa-assessing-potential-risk-liver-injury.html
Rights and permissions
About this article
Cite this article
Dabigatran etexilate (Pradaxa) linked with liver injury. Reactions Weekly 1702, 1 (2018). https://doi.org/10.1007/s40278-018-46111-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-46111-8